IP Library Granted Patent US 8,784,402
Granted Patent B1
US 8,784,402 · App. 13/950,585 · Granted Jul 22, 2014

Catheters with fluoropolymer additives

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,784,402
App. No.
13/950,585
Granted
Jul 22, 2014
Kind
B1
Abstract

The present invention provides catheter compositions that provide anti-thrombogenic properties while not adversely impacting mechanical properties. All embodiments of the present invention comprise a catheter that comprises a fluoropolymer additive with specific compositions and/or purity levels.

Claims (13)

1. A catheter comprising:

an elongated tubular structure comprising:

a polymeric material;

an outer surface, a proximal end, a distal end, and a lumen, wherein said outer surface and said lumen extend between said proximal and distal ends; and

a wall thickness between said outer surface and said lumen, said wall thickness being at least 0.005 inches;

wherein said polymeric material comprises polyurethane and additives, said additives comprising 25-35 weight percent of a radiopaque material, 1.5-2.5 weight percent of a polymer comprising terminal polyfluoro-oligomeric groups, and a colorant.

2. The catheter of claim 1 , wherein said polymeric material is comprised of a positive amount of up to about 40 weight percent of said additives.

3. The catheter of claim 1 , wherein said polymeric material is comprised of a positive amount of up to about 33 weight percent of said additives.

4. The catheter of claim 1 , wherein said polymeric material comprises a positive amount of up to about 2.0 weight percent of said colorant.

5. The catheter of claim 4 , wherein said polymeric material comprises a positive amount of up to about 0.2 weight percent of said colorant.

6. The catheter of claim 1 , wherein said polymeric material comprises a positive amount of up to about 30 weight percent of said radiopaque material.

7. The catheter of claim 1 , wherein said radiopaque material comprises barium sulfate.

8. The catheter of claim 1 , wherein said elongated tubular structure comprises a plurality of lumens.

Assignments (8)
RELEASE OF SECURITY INTEREST Recorded Jun 8, 2023
From: JPMORGAN CHASE BANK, N.A., AS ADMINISTRATIVE AGENT
To: ANGIODYNAMICS, INC.
Reel/Frame 063940/0362 →
SECURITY INTEREST Recorded Aug 31, 2022
From: ANGIODYNAMICS, INC.
To: JPMORGAN CHASE BANK, N.A., AS ADMINISTRATIVE AGENT
Reel/Frame 061360/0668 →
RELEASE OF SECURITY INTEREST Recorded Aug 31, 2022
From: JPMORGAN CHASE BANK, N.A., AS ADMINISTRATIVE AGENT
To: ANGIODYNAMICS, INC.
Reel/Frame 061363/0446 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 10, 2019
From: INTERFACE BIOLOGICS, INC.
To: EVONIK CANADA INC.
Reel/Frame 050683/0425 →
CONFIRMATORY GRANT OF SECURITY INTEREST IN UNITED STATES PATENTS Recorded Jun 5, 2019
From: ANGIODYNAMICS, INC.
To: JPMORGAN CHASE BANK, N.A., AS ADMINISTRATIVE AGENT
Reel/Frame 049371/0657 →
SECURITY INTEREST Recorded Nov 8, 2016
From: ANGIODYNAMICS, INC.
To: JPMORGAN CHASE BANK, N.A., AS ADMINISTRATIVE AGENT
Reel/Frame 040613/0049 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 3, 2014
From: SANTERRE, J. PAUL; HO, JEANNETTE
To: INTERFACE BIOLOGICS INC.
Reel/Frame 032596/0812 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jul 29, 2013
From: LAREAU, RAYMOND; BELL, BENJAMIN
To: ANGIODYNAMICS, INC.
Reel/Frame 030892/0153 →